Under review simply means the FDA is still assessing: Safety Clinical relevance Regulatory appropriateness It does not mean: The peptide is approved The peptide is widely available The peptide is appropriate for general use At this stage, access to many of these substances may remain limited, inconsistent, or restricted, and quality can vary outside regulated pathways
Fasting matters
Hepatitis/Elevated liver enzymes/Jaundice Diabetic retinopathy problems: Changes in vision in those with Type 2 diabetes, particularly vision problems may worsen in those with a history of diabetic retinopathy Severe gastrointestinal disease - may cause gastrointestinal disease
Ipamorelin is a selective growth hormone secretagogue that triggers a clean GH pulse without raising cortisol or prolactin
This is the most damning data point in the entire supply-chain story
SeekPeptides provides detailed vendor evaluations, quality testing information, and protocol guidance that helps researchers make informed decisions regardless of which access route they choose